Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling

[1]  J. Powell,et al.  An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer , 2013, BMC Medical Genomics.

[2]  Jing-he Li,et al.  Positive ALDH1A3 and Negative GPX3 Expressions Are Biomarkers for Poor Prognosis of Gallbladder Cancer , 2013, Disease markers.

[3]  P. Benos,et al.  Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3 , 2013, Proceedings of the National Academy of Sciences.

[4]  L. Chin,et al.  HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome , 2013, Oncogene.

[5]  Subodh M. Lele,et al.  MUC4 Overexpression Augments Cell Migration and Metastasis through EGFR Family Proteins in Triple Negative Breast Cancer Cells , 2013, PloS one.

[6]  A. Nerlich,et al.  Density-dependent lineage instability of MDA-MB-435 breast cancer cells , 2013, Oncology letters.

[7]  S. Tommasi,et al.  HOX gene methylation status analysis in patients with hereditary breast cancer , 2012, Journal of Human Genetics.

[8]  M. McCarter,et al.  ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets , 2012, Stem cells.

[9]  Chin-Lee Wu,et al.  Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  T. Khoury,et al.  Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy , 2012, Modern Pathology.

[11]  Sung-Won Kim,et al.  Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes , 2012, Modern Pathology.

[12]  M. Goto,et al.  Mucins in human neoplasms: Clinical pathology, gene expression and diagnostic application , 2011, Pathology international.

[13]  Y. Miao,et al.  The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma , 2011, Medical oncology.

[14]  A. Pavlick,et al.  A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer , 2011, Investigational New Drugs.

[15]  V. Laudet,et al.  Genome-wide in Silico Identification of New Conserved and Functional Retinoic Acid Receptor Response Elements (Direct Repeats Separated by 5 bp)* , 2011, The Journal of Biological Chemistry.

[16]  Jin-Haeng Chung,et al.  DNA methylation profile during multistage progression of pulmonary adenocarcinomas , 2011, Virchows Archiv.

[17]  J. Mackey,et al.  Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy. , 2011, The American journal of pathology.

[18]  J. Wagner,et al.  Retinoids regulate stem cell differentiation , 2011, Journal of cellular physiology.

[19]  L. Gudas,et al.  Retinoids, retinoic acid receptors, and cancer. , 2011, Annual review of pathology.

[20]  Patrick W. Lee,et al.  Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis , 2011, Stem cells.

[21]  M. Hallett,et al.  Stromal retinoic acid receptor β promotes mammary gland tumorigenesis , 2010, Proceedings of the National Academy of Sciences.

[22]  J. Reis-Filho,et al.  Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment , 2010, Breast Cancer Research and Treatment.

[23]  S. Agarwal,et al.  In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. , 2010, The American journal of pathology.

[24]  F. Bertucci,et al.  Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer , 2009, Clinical Cancer Research.

[25]  Zhenqiu Liu,et al.  ALDH1A1 Is a Marker for Malignant Prostate Stem Cells and Predictor of Prostate Cancer Patients’ Outcome , 2009, Laboratory Investigation.

[26]  S. Mader,et al.  Kinetic characterization of recombinant mouse retinal dehydrogenase types 3 and 4 for retinal substrates. , 2009, Biochimica et biophysica acta.

[27]  V. Vasiliou,et al.  The Aldehyde Dehydrogenase Gene Superfamily Resource Center , 2009, Human Genomics.

[28]  F. Bertucci,et al.  Retinoid signaling regulates breast cancer stem cell differentiation , 2009, Cell cycle.

[29]  A. Hollestelle,et al.  Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma? , 2009, Cancer research.

[30]  N. Cho,et al.  CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma , 2009, Virchows Archiv.

[31]  A. Chambers,et al.  MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? , 2009, Cancer research.

[32]  T. Taguchi,et al.  Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression , 2009, Cancer science.

[33]  M. Goto,et al.  Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior , 2008, Proteomics.

[34]  C. Brocker,et al.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily , 2008, Expert opinion on drug metabolism & toxicology.

[35]  T. Schug,et al.  Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR , 2008, Proceedings of the National Academy of Sciences.

[36]  S. Batra,et al.  Structure, evolution, and biology of the MUC4 mucin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  F. di Costanzo,et al.  Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial. , 2007, Acta bio-medica : Atenei Parmensis.

[38]  D. Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[39]  M. McGrane.  Vitamin A regulation of gene expression: molecular mechanism of a prototype gene. , 2007, The Journal of nutritional biochemistry.

[40]  T. Schug,et al.  Opposing Effects of Retinoic Acid on Cell Growth Result from Alternate Activation of Two Different Nuclear Receptors , 2007, Cell.

[41]  Taylor Jensen,et al.  Epigenetic inactivation of the HOXA gene cluster in breast cancer. , 2006, Cancer research.

[42]  J. Moreb,et al.  RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide , 2006, Cancer Chemotherapy and Pharmacology.

[43]  Yoko Takahashi,et al.  Aberrant expression of HOX genes in human invasive breast carcinoma. , 2005, Oncology Report.

[44]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[45]  G. Duester,et al.  Enzymatic characterization of recombinant mouse retinal dehydrogenase type 1. , 2003, Biochemical pharmacology.

[46]  R. Blomhoff,et al.  Gene expression regulation by retinoic acid Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.R100015-JLR200 , 2002, Journal of Lipid Research.

[47]  S. Singletary,et al.  Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  Lakshmaiah Sreerama,et al.  Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study , 2002, Cancer Chemotherapy and Pharmacology.

[49]  D. Ong,et al.  Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. , 2001, Cancer research.

[50]  P. Adamson,et al.  Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  P. Penzes,et al.  Enzymatic characteristics of retinal dehydrogenase type I expressed in Escherichia coli. , 1997, Biochimica et biophysica acta.

[52]  U. Dräger,et al.  Molecular identification of a major retinoic-acid-synthesizing enzyme, a retinaldehyde-specific dehydrogenase. , 1996, European journal of biochemistry.

[53]  R. Stephens,et al.  Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.

[54]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[55]  O. Woo,et al.  Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer. , 2014, Neoplasma.

[56]  T. Jiang,et al.  Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. , 2013, Cancer letters.

[57]  C. Brocker,et al.  Non-P 450 aldehyde oxidizing enzymes : the aldehyde dehydrogenase superfamily , 2009 .

[58]  A. Nerlich,et al.  Lineage infidelity and expression of melanocytic markers in human breast cancer. , 2008, International journal of oncology.

[59]  Eric P. Winer,et al.  Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial , 1997, Cancer Chemotherapy and Pharmacology.

[60]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[61]  I. Fidler,et al.  Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. , 1991, Invasion & metastasis.